Schizophrenia-Reference-Cited by-同舟云学术

Schizophrenia

Published:2015-11-12 Issue:1 Volume:1 Page:
ISSN:2056-676X
Container-title:Nature Reviews Disease Primers
language:en
Short-container-title:Nat Rev Dis Primers

Author:

Kahn René S.,Sommer Iris E.,Murray Robin M.,Meyer-Lindenberg Andreas,Weinberger Daniel R.,Cannon Tyrone D.,O'Donovan Michael,Correll Christoph U.,Kane John M.,van Os Jim,Insel Thomas R.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://www.nature.com/articles/nrdp201567.pdf

Reference247 articles.

1. Kahn, R. S. & Keefe, R. S. E. Schizophrenia is a cognitive illness: time for a change in focus. JAMA Psychiatry 70, 1107–1112 (2013). This study emphasizes that cognition should be recognized as the core component of schizophrenia. Diagnostic efforts should highlight the changes in cognitive function that occur earlier in development. Putting the focus back on cognition might facilitate finding treatments for the illness before psychosis ever emerges.

2. Laursen, T. M., Nordentoft, M. & Mortensen, P. B. Excess early mortality in schizophrenia. Annu. Rev. Clin. Psychol. 10, 425–448 (2014).

3. Harvey, P. D. Assessing disability in schizophrenia: tools and contributors. J. Clin. Psychiatry 75, e27 (2014).

4. Reichenberg, A. et al. The course and correlates of everyday functioning in schizophrenia. Schizophr. Res. Cogn. 1, e47–e52 (2014).

5. Michalopoulou, P. G., Lewis, S. W., Wykes, T., Jaeger, J. & Kapur, S. Treating impaired cognition in schizophrenia: the case for combining cognitive-enhancing drugs with cognitive remediation. Eur. Neuropsychopharmacol. 23, 790–798 (2013).

Cited by 843 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secular trends in the prevalence of schizophrenia among different age, period and cohort groups between 1990 and 2019;Asian Journal of Psychiatry;2024-11

2. Immune-based Machine learning Prediction of Diagnosis and Illness State in Schizophrenia and Bipolar Disorder;Brain, Behavior, and Immunity;2024-11

3. Bridging the gap: Prenatal nutrition, myelination, and schizophrenia etiopathogenesis;Neuroscience;2024-10

4. Conceptualization and characterization of “primary” and “secondary” cognitive impairment in schizophrenia;Psychiatry Research;2024-10

5. Safety, tolerability and pharmacokinetics of the phosphodiesterase 2 inhibitor BI 474121: An overview of phase I randomized trials in healthy volunteers;Journal of Psychopharmacology;2024-09-12